Literature DB >> 19021119

Sickle cell disease summit: from clinical and research disparity to action.

Kathryn Hassell1, Betty Pace, Winfred Wang, Roshni Kulkarni, Naomi Luban, Cage S Johnson, James Eckman, Peter Lane, William G Woods.   

Abstract

The American Society of Pediatric Hematology/Oncology Sickle Cell Summit brought together a broad range of constituencies to identify a unified approach to healthcare and research disparities for sickle cell disease. Recommendations included the following: (1) speak with a unified voice representing all constituencies; (2) optimize access to care from knowledgeable health care providers and create a medical home for all individuals with the disease; (3) utilize population-based surveillance to measure outcomes; (4) develop overall approaches to basic, translational, clinical, and health services research; (5) enhance the community role in advocacy, education, service, and fundraising. Taskforces were identified to effect implementation.

Mesh:

Year:  2009        PMID: 19021119     DOI: 10.1002/ajh.21315

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Sickle cell disease--the American saga.

Authors:  Azfar-E-Alam Siddiqi; Lanetta B Jordan; Christopher S Parker
Journal:  Ethn Dis       Date:  2013       Impact factor: 1.847

2.  Usability testing of a Smartphone for accessing a web-based e-diary for self-monitoring of pain and symptoms in sickle cell disease.

Authors:  Eufemia Jacob; Jennifer Stinson; Joana Duran; Ankur Gupta; Mario Gerla; Mary Ann Lewis; Lonnie Zeltzer
Journal:  J Pediatr Hematol Oncol       Date:  2012-07       Impact factor: 1.289

3.  Concentration of hospital care for acute sickle cell disease-related visits.

Authors:  J A Panepinto; P L Owens; A L Mosso; C A Steiner; D C Brousseau
Journal:  Pediatr Blood Cancer       Date:  2011-12-16       Impact factor: 3.167

Review 4.  Reducing Health Care Disparities in Sickle Cell Disease: A Review.

Authors:  LaTasha Lee; Kim Smith-Whitley; Sonja Banks; Gary Puckrein
Journal:  Public Health Rep       Date:  2019-10-10       Impact factor: 2.792

5.  Bounded Justice and the Limits of Health Equity.

Authors:  Melissa S Creary
Journal:  J Law Med Ethics       Date:  2021       Impact factor: 1.718

6.  Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents.

Authors:  Nancy A Omondi; Stacy E Stickney Ferguson; Navneet S Majhail; Ellen M Denzen; George R Buchanan; Ann E Haight; Richard J Labotka; J Douglas Rizzo; Elizabeth A Murphy
Journal:  J Pediatr Hematol Oncol       Date:  2013-05       Impact factor: 1.289

7.  Simple chronic transfusion therapy, a crucial therapeutic option for sickle cell disease, improves but does not normalize blood rheology: What should be our goals for transfusion therapy?

Authors:  Jon A Detterich
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

8.  Fatigue in adolescents and young adults with sickle cell disease: biological and behavioral correlates and health-related quality of life.

Authors:  Suzanne Ameringer; R K Elswick; Wally Smith
Journal:  J Pediatr Oncol Nurs       Date:  2013-12-30       Impact factor: 1.636

9.  Improving an Administrative Case Definition for Longitudinal Surveillance of Sickle Cell Disease.

Authors:  Angela B Snyder; Mei Zhou; Rodney Theodore; Maa-Ohui Quarmyne; James Eckman; Peter A Lane
Journal:  Public Health Rep       Date:  2019-04-10       Impact factor: 2.792

10.  State-based surveillance for selected hemoglobinopathies.

Authors:  Mary M Hulihan; Lisa Feuchtbaum; Lanetta Jordan; Russell S Kirby; Angela Snyder; William Young; Yvonne Greene; Joseph Telfair; Ying Wang; William Cramer; Ellen M Werner; Kristy Kenney; Melissa Creary; Althea M Grant
Journal:  Genet Med       Date:  2014-07-03       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.